Commercial Execution Of SublocadeSuccessful commercial execution of Sublocade could substantially expand penetration of long-acting injectables and drive meaningful revenue growth for the company.
Margin Expansion And Cost ReductionsGuidance pointing to significant margin expansion, supported by deeper-than-expected cost reductions, could materially improve profitability and strengthen cash generation.
Strategic Focus And Capital DeploymentA strategic shift toward expanding EBITDA, generating cash, and deploying capital makes execution and earnings the primary investment drivers and could support valuation upside if execution aligns with targets.